In the second part of our special on Nutrigenomics, we take a look at the progress to date, from the first reports of DNA to predictions of nutrigenomic foods filling supermarket shelves (everyone says they're 5-10 years away...).
The events presented are not intended to be exhaustive of all milestones, but to present a brief view of progress to date.
Understanding and achieving nutrition’s potential to maintain health and prevent disease may lie with the study of epigenetics, according to a new review.
As genetic testing advances, and commercial tests increase in number, FDA oversight of the tests will strengthen, but it will remain a challenge to not stifle future innovation, says an academic from Duke University.
At the recent IFT Annual Meeting and Expo, Stephen Daniells talked to Dr Jim Kaput, director of FDA’s Division of Personalized Nutrition and Medicine about the paradigm shift needed to move personalized nutrition forward.